Clinician's Roundtable

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG Guest: Rob Olson, MD The OB/GYN hospitalist model is one potential approach to enhancing the quality and safety of hospital’s obstetric–gynecologic services and reducing the incidence of adverse events Host Dr. Renee Allen sits down with Dr. Rob Olson, an OB/GYN hospitalist program consultant with over 7 years experience practicing in this role. Dr. Olson is founding President of the newly formed Society of OB/GYN Hospitalists, and he speaks nationally on the many benefits of OB/GYN Hospitalist models of care.

Host: Ana Maria Rosario Guest: Martin R. Chavez, MD, FACOG From the Women's Health Annual Visit in Chicago, host Ana Maria Rosario talks with Dr. Martin Chavez, the Director of Maternal Fetal Medicine and Fetal Surgery Program at Winthrop University Hospital, about the maternal-fetal effects of the Zika virus outbreak.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Reports indicate that there is a national upsurge in the number of women with opioid addiction. The problem is multigenerational, with consumption habits that begin as early as the mid-teenage years and extend well into the elderly population. Additionally, opioid addiction disproportionately affects women, who are more likely to become dependent and overdose unintentionally on painkillers compared to men. Host Dr. Patrice Basanta-Henry talks with Dr. Regan Theiler, Director of the Division of General OB/GYN at Dartmouth-Hitchcock Medical Center about treatment approaches for opioid-addicted pregnant women and women of childbearing age.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Prescription drugs are often essential to the management of both acute and chronic pain. However, misuse, abuse and additions to these products, especially opioids, have become a worldwide epidemic. Since 1999, the number of overdose deaths involving opioids have almost quadrupled in the United States. Host Dr. Patrice Basanta-Henry talks with psychiatrist and addiction medicine specialist Dr. Nzinga Harrison, CMO of Anka Behavioral Health Inc., about the physician's role in the face of this opioid epidemic.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG Many menopausal and perimenopausal women are faced with the decision of whether synthetic or bioidentical hormone therapy is the best option for them. There are many pros and cons for each, but questions surface from patients and clinicians alike on comparative safety and efficacy profiles. Host Dr. Renee Allen welcomes Dr. Jocelyn Slaughter-Moore, a board-certified practicing OB/GYN at Heras Healthcare for Women. They talk about the differences between bioidentical and synthetic hormones, and whether bioidentical hormone therapy is a safe option for women.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Advances in technology have resulted in increased information being available for pregnant woman. With this increased information has come a rise in the number of requests for termination of pregnancy for fetal indications. However, termination of pregnancy remains a controversial issue in the area of women’s health. Women requesting second trimester terminations may face significant legal barriers as well as poor access to providers and/or facilities that are able to provide the procedure. Host Dr. Patrice Basanta-Henry chats with Dr. Reagan Theiler, Division Director for General Obstetrics and Gynecology and Director of Ryan Residency Training Program at the Dartmouth Hitchcock Center and the controversy surrounding second trimester termination.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG According to the American Congress of Obstetricians and Gynecologists, between 14% and 23% of women will struggle with some symptoms of depression during their pregnancy. This condition often goes unrecognized and untreated in part because of safety concerns in using medications or other therapeutic methods during pregnancy. Host Dr. Patrice Basanta-Henry talks with Dr. Nzinga Harrison, a board-certified physician in addiction medicine and psychiatry and Chief Medical Officer for Anka Behavioral Health, Inc about the current recommendations for depression screenings in the pregnant patient.

Host: Ana Maria Rosario Guest: David Gandell, MD Genital Herpes Simplex Virus (HSV) infection is a major public health problem. A dramatic upsurge in genital HSV infections have been documented from several prominent studies, making recognition, treatment, and patient counseling strategies more important than ever. Joining host, Ana Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. David Gandell, Clinical Professor of Obstetrics and Gynecology at the University of Rochester and attending phsyician at Strong Memorial Hospital.

Host: Patrice L Basanta-Henry, MD, MHSc, FACOG Approximately just 0.5% of all births occur before the third trimester of pregnancy, yet these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. Care for infants born at the threshold of viability, less than 24 weeks of gestation and with body weights less than 1000 grams, poses many difficult clinical, social, and ethical questions among clinicians and families. Host Dr. Patrice Basanta-Henry speaks with guest Dr. Fyama Wenner, a maternal-fetal medicine specialist at Atlanta Maternal Fetal Medicine, about special care considerations for extremely preterm infants, as well as effective counseling strategies for families.

Host: Ana Maria Rosario Guest: Anita L. Nelson, MD Joining host Ana Maria Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. Anita Nelson, professor emeritus at UCLA and professor and chair of OB/GYN at Western University in California. The two discuss patient barriers to accessing IUDs and implants in a rapidly growing contraceptive market.